Table of Content

Table of Contents

1 Product Introduction and Overview
1.1 Product Definition
1.2 Product Specification
1.3 Global Market Overview
1.3.1 Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Status and Forecast (2016-2027)
1.3.2 Global Chemotheraphy-induced Nausea and Vomitting Treatment Sales Value CAGR by Region
1.4 Market Drivers, Inhibitors
1.4.1 Market Drivers
1.4.2 Market Inhibitors
1.4.3 COVID-19 Impact Analysis
2 Global Chemotheraphy-induced Nausea and Vomitting Treatment Supply by Company
2.1 Global Chemotheraphy-induced Nausea and Vomitting Treatment Sales Volume by Company
2.2 Global Chemotheraphy-induced Nausea and Vomitting Treatment Sales Value by Company
2.3 Global Chemotheraphy-induced Nausea and Vomitting Treatment Price by Company
2.4 Chemotheraphy-induced Nausea and Vomitting Treatment Production Location and Sales Area of Main Manufacturers
2.5 Trend of Concentration Rate
3 Global and Regional Chemotheraphy-induced Nausea and Vomitting Treatment Market Status by Type
3.1 Chemotheraphy-induced Nausea and Vomitting Treatment Type Introduction
3.1.1 Aloxi (Palonosetron)
3.1.2 Kytril (Granisetron)
3.1.3 Emend (Aprepitant)
3.1.4 Others
3.2 Global Chemotheraphy-induced Nausea and Vomitting Treatment Market by Type
3.2.1 Global Chemotheraphy-induced Nausea and Vomitting Treatment Sales Volume by Type (2016-2021)
3.2.2 Global Chemotheraphy-induced Nausea and Vomitting Treatment Sales Value by Type (2016-2021)
3.2.3 Global Chemotheraphy-induced Nausea and Vomitting Treatment Price by Type (2016-2021)
3.3 North America: by Type
3.4 Europe: by Type
3.5 Asia Pacific: by Type
3.6 Central & South America: by Type
3.7 Middle East & Africa: by Type
4 Global and Regional Chemotheraphy-induced Nausea and Vomitting Treatment Market Status by Application
4.1 Chemotheraphy-induced Nausea and Vomitting Treatment Segment by Application
4.1.1 Acute Nausea and Vomitting Treatment
4.1.2 Delayed Nausea and Vomitting Treatment
4.1.3 Anticipatory Nausea and Vomitting Treatment
4.2 Global Chemotheraphy-induced Nausea and Vomitting Treatment Market by Application
4.2.1 Global Chemotheraphy-induced Nausea and Vomitting Treatment Sales Volume by Application (2016-2021)
4.2.2 Global Chemotheraphy-induced Nausea and Vomitting Treatment Sales Value by Application (2016-2021)
4.2.3 Global Chemotheraphy-induced Nausea and Vomitting Treatment Price by Application (2016-2021)
4.3 North America: by Application
4.4 Europe: by Application
4.5 Asia Pacific: by Application
4.6 Central & South America: by Application
4.7 Middle East & Africa: by Application
5 Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Status by Region
5.1 Global Chemotheraphy-induced Nausea and Vomitting Treatment Market by Region
5.1.1 Global Chemotheraphy-induced Nausea and Vomitting Treatment Sales Volume by Region
5.1.2 Global Chemotheraphy-induced Nausea and Vomitting Treatment Sales Value by Region
5.2 North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Status
5.3 Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Status
5.4 Asia Pacific Chemotheraphy-induced Nausea and Vomitting Treatment Market Status
5.5 Central & South America Chemotheraphy-induced Nausea and Vomitting Treatment Market Status
5.6 Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market Status
6 North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Status
6.1 North America Chemotheraphy-induced Nausea and Vomitting Treatment Market by Country
6.1.1 North America Chemotheraphy-induced Nausea and Vomitting Treatment Sales Volume by Country (2016-2021)
6.1.2 North America Chemotheraphy-induced Nausea and Vomitting Treatment Sales Value by Country (2016-2021)
6.2 United States
6.3 Canada
6.4 Mexico
7 Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Status
7.1 Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market by Country
7.1.1 Europe Chemotheraphy-induced Nausea and Vomitting Treatment Sales Volume by Country (2016-2021)
7.1.2 Europe Chemotheraphy-induced Nausea and Vomitting Treatment Sales Value by Country (2016-2021)
7.2 Germany
7.3 France
7.4 UK
7.5 Italy
7.6 Russia
7.7 Spain
8 Asia Pacific Chemotheraphy-induced Nausea and Vomitting Treatment Market Status
8.1 Asia Pacific Chemotheraphy-induced Nausea and Vomitting Treatment Market by Country
8.1.1 Asia Pacific Chemotheraphy-induced Nausea and Vomitting Treatment Sales Volume by Country (2016-2021)
8.1.2 Asia Pacific Chemotheraphy-induced Nausea and Vomitting Treatment Sales Value by Country (2016-2021)
8.2 China
8.3 Japan
8.4 Korea
8.5 Southeast Asia
8.6 India
8.7 Australasia
9 Central & South America Chemotheraphy-induced Nausea and Vomitting Treatment Market Status
9.1 Central & South America Chemotheraphy-induced Nausea and Vomitting Treatment Market by Country
9.1.1 Central & South America Chemotheraphy-induced Nausea and Vomitting Treatment Sales Volume by Country (2016-2021)
9.1.2 Central & South America Chemotheraphy-induced Nausea and Vomitting Treatment Sales Value by Country (2016-2021)
9.2 Brazil
9.3 Argentina
9.4 Colombia
10 Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market Status
10.1 Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market by Country
10.1.1 Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Sales Volume by Country (2016-2021)
10.1.2 Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Sales Value by Country (2016-2021)
10.2 Iran
10.3 Israel
10.4 Turkey
10.5 South Africa
10.8 Saudi Arabia
11 Supply Chain and Manufacturing Cost Analysis
11.1 Supply Chain Analysis
11.2 Production Process Chart Analysis
11.3 Raw Materials and Key Suppliers Analysis
11.3.1 Raw Materials Introduction
11.3.2 Raw Materials Key Suppliers List
11.4 Chemotheraphy-induced Nausea and Vomitting Treatment Manufacturing Cost Analysis
11.5 Chemotheraphy-induced Nausea and Vomitting Treatment Sales Channel and Distributors Analysis
11.5.1 Chemotheraphy-induced Nausea and Vomitting Treatment Sales Channel
11.5.2 Chemotheraphy-induced Nausea and Vomitting Treatment Distributors
11.6 Chemotheraphy-induced Nausea and Vomitting Treatment Downstream Major Buyers
12 Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Forecast by Type and by Application
12.1 Global Chemotheraphy-induced Nausea and Vomitting Treatment Sales Volume and Sales Value Forecast (2022-2027)
12.2 Global Chemotheraphy-induced Nausea and Vomitting Treatment Forecast by Type
12.2.1 Global Chemotheraphy-induced Nausea and Vomitting Treatment Sales Volume Forecast by Type
12.2.2 Global Chemotheraphy-induced Nausea and Vomitting Treatment Sales Value Forecast by Type
12.2.3 Global Chemotheraphy-induced Nausea and Vomitting Treatment Price Forecast by Type
12.3 Global Chemotheraphy-induced Nausea and Vomitting Treatment Forecast by Application
12.3.1 Global Chemotheraphy-induced Nausea and Vomitting Treatment Sales Volume Forecast by Application
12.3.2 Global Chemotheraphy-induced Nausea and Vomitting Treatment Sales Value Forecast by Application
12.3.3 Global Chemotheraphy-induced Nausea and Vomitting Treatment Price Forecast by Application
13 Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Forecast by Region/Country
13.1 Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Forecast by Region (2022-2027)
13.1.1 Global Chemotheraphy-induced Nausea and Vomitting Treatment Sales Volume Forecast by Region (2022-2027)
13.1.2 Global Chemotheraphy-induced Nausea and Vomitting Treatment Sales Value Forecast by Region (2022-2027)
13.2 North America Market Forecast
13.3 Europe Market Forecast
13.4 Asia Pacific Market Forecast
13.5 Central & South America Market Forecast
13.6 Middle East & Africa Market Forecast
14 Key Participants Company Information
14.1 Tesaro
14.1.1 Company Information
14.1.2 Chemotheraphy-induced Nausea and Vomitting Treatment Product Introduction
14.1.3 Tesaro Chemotheraphy-induced Nausea and Vomitting Treatment Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.1.4 SWOT Analysis
14.2 Orchid Healthcare
14.2.1 Company Information
14.2.2 Chemotheraphy-induced Nausea and Vomitting Treatment Product Introduction
14.2.3 Orchid Healthcare Chemotheraphy-induced Nausea and Vomitting Treatment Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.2.4 SWOT Analysis
14.3 OPKO Health
14.3.1 Company Information
14.3.2 Chemotheraphy-induced Nausea and Vomitting Treatment Product Introduction
14.3.3 OPKO Health Chemotheraphy-induced Nausea and Vomitting Treatment Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.3.4 SWOT Analysis
14.4 Mylan Pharmaceuticals
14.4.1 Company Information
14.4.2 Chemotheraphy-induced Nausea and Vomitting Treatment Product Introduction
14.4.3 Mylan Pharmaceuticals Chemotheraphy-induced Nausea and Vomitting Treatment Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.4.4 SWOT Analysis
14.5 Mundipharma
14.5.1 Company Information
14.5.2 Chemotheraphy-induced Nausea and Vomitting Treatment Product Introduction
14.5.3 Mundipharma Chemotheraphy-induced Nausea and Vomitting Treatment Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.5.4 SWOT Analysis
14.6 Merck & Co
14.6.1 Company Information
14.6.2 Chemotheraphy-induced Nausea and Vomitting Treatment Product Introduction
14.6.3 Merck & Co Chemotheraphy-induced Nausea and Vomitting Treatment Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.6.4 SWOT Analysis
14.7 Heron Therapeutics
14.7.1 Company Information
14.7.2 Chemotheraphy-induced Nausea and Vomitting Treatment Product Introduction
14.7.3 Heron Therapeutics Chemotheraphy-induced Nausea and Vomitting Treatment Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.7.4 SWOT Analysis
14.8 Helsinn
14.8.1 Company Information
14.8.2 Chemotheraphy-induced Nausea and Vomitting Treatment Product Introduction
14.8.3 Helsinn Chemotheraphy-induced Nausea and Vomitting Treatment Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.8.4 SWOT Analysis
14.9 GlaxoSmithKline
14.9.1 Company Information
14.9.2 Chemotheraphy-induced Nausea and Vomitting Treatment Product Introduction
14.9.3 GlaxoSmithKline Chemotheraphy-induced Nausea and Vomitting Treatment Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.9.4 SWOT Analysis
14.10 F.Hoffmann La Roche
14.10.1 Company Information
14.10.2 Chemotheraphy-induced Nausea and Vomitting Treatment Product Introduction
14.10.3 F.Hoffmann La Roche Chemotheraphy-induced Nausea and Vomitting Treatment Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.10.4 SWOT Analysis
14.11 Especificos Stendhal
14.12 Eisai
14.13 Baxter Healthcare
14.14 Barr Laboratories
14.15 Aphios
14.16 Acacia Pharma
15 Conclusion
16 Methodology

List of Figure

List of Tables

Table Global Chemotheraphy-induced Nausea and Vomitting Treatment Sales Value and CAGR by Region (2016-2027)
Table Global Chemotheraphy-induced Nausea and Vomitting Treatment Sales Volume by Company (2019-2021)
Table Global Chemotheraphy-induced Nausea and Vomitting Treatment Sales Volume Market Share by Company (2019-2021)
Table Global Chemotheraphy-induced Nausea and Vomitting Treatment Sales Value by Company (2019-2021)
Table Global Chemotheraphy-induced Nausea and Vomitting Treatment Sales Value and CAGR by Region (2016-2027)
Table Global Chemotheraphy-induced Nausea and Vomitting Treatment Price by Company (2019-2021)
Table Main Manufacturers Chemotheraphy-induced Nausea and Vomitting Treatment Product Location and Sales Area
Table Global Chemotheraphy-induced Nausea and Vomitting Treatment Sales Value by Company (2019-2021)
Table Global Chemotheraphy-induced Nausea and Vomitting Treatment Sales Volume by Type (2016-2021)
Table Global Chemotheraphy-induced Nausea and Vomitting Treatment Sales Volume Market Share by Type (2016-2021)
Table Global Chemotheraphy-induced Nausea and Vomitting Treatment Sales Value by Type (2016-2021)
Table Global Chemotheraphy-induced Nausea and Vomitting Treatment Sals Value Market Share by Type (2016-2021)
Table Global Chemotheraphy-induced Nausea and Vomitting Treatment Price by Type (2016-2021)
Table North America Chemotheraphy-induced Nausea and Vomitting Treatment Sales Volume by Type (2016-2021)
Table Global Chemotheraphy-induced Nausea and Vomitting Treatment Sales Value by Type (2016-2021)
Table Europe Chemotheraphy-induced Nausea and Vomitting Treatment Sales Volume by Type (2016-2021)
Table Europe Chemotheraphy-induced Nausea and Vomitting Treatment Sales Volume Market Share by Type (2016-2021)
Table Asia Pacific Chemotheraphy-induced Nausea and Vomitting Treatment Sales Volume by Type (2016-2021)
Table Asia Pacific Chemotheraphy-induced Nausea and Vomitting Treatment Sales Volume Market Share by Type (2016-2021)
Table Central & South America Chemotheraphy-induced Nausea and Vomitting Treatment Sales Volume by Type (2016-2021)
Table Central & South America Pacific Chemotheraphy-induced Nausea and Vomitting Treatment Sales Volume Market Share by Type (2016-2021)
Table Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Sales Volume by Type (2016-2021)
Table Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Sales Volume Market Share by Type (2016-2021)
Table Global Chemotheraphy-induced Nausea and Vomitting Treatment Sales Volume by Application (2016-2021)
Table Global Chemotheraphy-induced Nausea and Vomitting Treatment Sales Volume Market Share by Application (2016-2021)
Table Global Chemotheraphy-induced Nausea and Vomitting Treatment Sales Value by Application (2016-2021)
Table Global Chemotheraphy-induced Nausea and Vomitting Treatment Value Market Share by Application (2016-2021)
Table Global Chemotheraphy-induced Nausea and Vomitting Treatment Price by Application (2016-2021)
Table North America Chemotheraphy-induced Nausea and Vomitting Treatment Sales Volume by Application (2016-2021)
Table Global Chemotheraphy-induced Nausea and Vomitting Treatment Sales Value by Application (2016-2021)
Table Europe Chemotheraphy-induced Nausea and Vomitting Treatment Sales Volume by Application (2016-2021)
Table Europe Chemotheraphy-induced Nausea and Vomitting Treatment Sales Volume Market Share by Application (2016-2021)
Table Asia Pacific Chemotheraphy-induced Nausea and Vomitting Treatment Sales Volume by Application (2016-2021)
Table Asia Pacific Chemotheraphy-induced Nausea and Vomitting Treatment Sales Volume Market Share by Application (2016-2021)
Table Central & South America Chemotheraphy-induced Nausea and Vomitting Treatment Sales Volume by Application (2016-2021)
Table Central & South America Pacific Chemotheraphy-induced Nausea and Vomitting Treatment Sales Volume Market Share by Application (2016-2021)
Table Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Sales Volume by Application (2016-2021)
Table Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Sales Volume Market Share by Application (2016-2021)
Table Global Chemotheraphy-induced Nausea and Vomitting Treatment Sales Volume by Region (2016-2021)
Table Global Chemotheraphy-induced Nausea and Vomitting Treatment Sales Volume Market Share by Region (2016-2021)
Table Global Chemotheraphy-induced Nausea and Vomitting Treatment Sales Value by Region (2016-2021)
Table Global Chemotheraphy-induced Nausea and Vomitting Treatment Value Market Share by Region (2016-2021)
Table North America Chemotheraphy-induced Nausea and Vomitting Treatment Sales Volume by Country (2016-2021)
Table North America Chemotheraphy-induced Nausea and Vomitting Treatment Sales Volume Market Share by Country (2016-2021)
Table Global Chemotheraphy-induced Nausea and Vomitting Treatment Sales Value by Region/Country (2016-2021)
Table North America Chemotheraphy-induced Nausea and Vomitting Treatment Value Market Share by Country (2016-2021)
Table Europe Chemotheraphy-induced Nausea and Vomitting Treatment Sales Volume by Country (2016-2021)
Table Europe Chemotheraphy-induced Nausea and Vomitting Treatment Sales Volume Market Share by Country (2016-2021)
Table Europe Chemotheraphy-induced Nausea and Vomitting Treatment Sales Value by Country (2016-2021)
Table Europe Chemotheraphy-induced Nausea and Vomitting Treatment Value Market Share by Country (2016-2021)
Table Asia Pacific Chemotheraphy-induced Nausea and Vomitting Treatment Sales Volume by Country (2016-2021)
Table Asia Pacific Chemotheraphy-induced Nausea and Vomitting Treatment Sales Volume Market Share by Country (2016-2021)
Table Asia Pacific Chemotheraphy-induced Nausea and Vomitting Treatment Sales Value by Country (2016-2021)
Table Asia Pacific Chemotheraphy-induced Nausea and Vomitting Treatment Value Market Share by Country (2016-2021)
Table Central & South America Chemotheraphy-induced Nausea and Vomitting Treatment Sales Volume by Country (2016-2021)
Table Central & South America Chemotheraphy-induced Nausea and Vomitting Treatment Sales Volume Market Share by Country (2016-2021)
Table Central & South America Chemotheraphy-induced Nausea and Vomitting Treatment Sales Value by Country (2016-2021)
Table Central & South America Chemotheraphy-induced Nausea and Vomitting Treatment Value Market Share by Country (2016-2021)
Table Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Sales Volume by Country (2016-2021)
Table Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Sales Volume Market Share by Country (2016-2021)
Table Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Sales Value by Country (2016-2021)
Table Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Value Market Share by Country (2016-2021)
Table Chemotheraphy-induced Nausea and Vomitting Treatment Raw Materials Key Suppliers List
Table Chemotheraphy-induced Nausea and Vomitting Treatment Distributors List
Table Chemotheraphy-induced Nausea and Vomitting Treatment Buyers List
Table Global Chemotheraphy-induced Nausea and Vomitting Treatment Sales Volume Forecast by Type (2022-2027)
Table Global Chemotheraphy-induced Nausea and Vomitting Treatment Sales Volume Market Share Forecast by Type (2022-2027)
Table Global Chemotheraphy-induced Nausea and Vomitting Treatment Value Forecast by Type (2022-2027)
Table Global Chemotheraphy-induced Nausea and Vomitting Treatment Value Market Share Forecast by Type (2022-2027)
Table Global Chemotheraphy-induced Nausea and Vomitting Treatment Price Forecast by Type (2022-2027)
Table Global Chemotheraphy-induced Nausea and Vomitting Treatment Sales Volume Forecast by Application (2022-2027)
Table Global Chemotheraphy-induced Nausea and Vomitting Treatment Value Forecast by Type (2022-2027)
Table Global Chemotheraphy-induced Nausea and Vomitting Treatment Value Forecast by Application (2022-2027)
Table Global Chemotheraphy-induced Nausea and Vomitting Treatment Value Market Share Forecast by Application (2022-2027)
Table Global Chemotheraphy-induced Nausea and Vomitting Treatment Price Forecast by Application (2022-2027)
Table Global Chemotheraphy-induced Nausea and Vomitting Treatment Sales Volume Forecast by Region (2022-2027)
Table Global Chemotheraphy-induced Nausea and Vomitting Treatment Value Forecast by Application (2022-2027)
Table Global Chemotheraphy-induced Nausea and Vomitting Treatment Value Forecast by Region (2022-2027)
Table Global Chemotheraphy-induced Nausea and Vomitting Treatment Value Market Share Forecast by Region (2022-2027)
Table Tesaro Company Information
Table Tesaro Product Introduction
Table Global Chemotheraphy-induced Nausea and Vomitting Treatment Value Forecast by Region (2022-2027)
Table Orchid Healthcare Company Information
Table Orchid Healthcare Product Introduction
Table Orchid Healthcare Chemotheraphy-induced Nausea and Vomitting Treatment Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
Table OPKO Health Company Information
Table OPKO Health Product Introduction
Table OPKO Health Chemotheraphy-induced Nausea and Vomitting Treatment Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
Table Mylan Pharmaceuticals Company Information
Table Mylan Pharmaceuticals Product Introduction
Table Mylan Pharmaceuticals Chemotheraphy-induced Nausea and Vomitting Treatment Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
Table Mundipharma Company Information
Table Mundipharma Product Introduction
Table Mundipharma Chemotheraphy-induced Nausea and Vomitting Treatment Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
Table Merck & Co Company Information
Table Merck & Co Product Introduction
Table Merck & Co Chemotheraphy-induced Nausea and Vomitting Treatment Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
Table Heron Therapeutics Company Information
Table Heron Therapeutics Product Introduction
Table Heron Therapeutics Chemotheraphy-induced Nausea and Vomitting Treatment Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
Table Helsinn Company Information
Table Helsinn Product Introduction
Table Helsinn Chemotheraphy-induced Nausea and Vomitting Treatment Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
Table GlaxoSmithKline Company Information
Table GlaxoSmithKline Product Introduction
Table GlaxoSmithKline Chemotheraphy-induced Nausea and Vomitting Treatment Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
Table F.Hoffmann La Roche Company Information
Table F.Hoffmann La Roche Product Introduction
Table F.Hoffmann La Roche Chemotheraphy-induced Nausea and Vomitting Treatment Sales Volume, Price, Sales Value and Gross Margin (2019-2021)